Oct. 20, 2011
/PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading
-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited third quarter 2011 results after the NASDAQ stock market closes on
Thursday, November 10, 2011
Following the earnings announcement, 3SBio's senior management will host a conference call on
Friday, November 11, 2011
(US Pacific) /
(US Eastern) /
) to discuss its unaudited third quarter 2011 results and recent business activity. The conference call may be accessed using the dial-in numbers below:
International toll-free dial-in:
International toll dial-in:
65 6723 9381
Replay- Conference ID:
A telephone replay will be available two hours after the call until
November 19, 2011
A live webcast of the conference will be available on the investor relations section of 3SBio's website at
A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in
. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in
, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see
for more information.
Chief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820
Director of Investor Relations3SBio Inc. Tel: + 852 8191-6991
SOURCE 3SBio Inc.